Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 34, 2019 - Issue 1
Research Paper
Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening
, , , , , , , , , & 
show all
Makoto UbukataDivision of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Sapporo, Japan; Correspondence[email protected]
http://orcid.org/0000-0001-8911-2815View further author information
http://orcid.org/0000-0001-8911-2815View further author information show allRelated Research Data
Drug repurposing and human parasitic protozoan diseases
Source:
Published by Elsevier Ltd.
Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition.
Source:
Elsevier BV
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies.
Source:
Elsevier BV
Cryptosporidium parvum IMP Dehydrogenase IDENTIFICATION OF FUNCTIONAL, STRUCTURAL, AND DYNAMIC PROPERTIES THAT CAN BE EXPLOITED FOR DRUG DESIGN
Source:
Elsevier BV
Novel adenosine-derived inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
Source:
Springer Science and Business Media LLC
Cofactor mobility determines reaction outcome in the IMPDH and GMPR (β-α)8 barrel enzymes
Source:
Springer Science and Business Media LLC
Drug Repurposing: Far Beyond New Targets for Old Drugs
Source:
Springer Science and Business Media LLC
Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways
Source:
Springer Science and Business Media LLC
Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products
Source:
American Chemical Society (ACS)
Effects of long duration, low dose bronopol exposure on the control of Ichthyophthirius multifiliis (Ciliophora), parasitising rainbow trout (Oncorhynchus mykiss Walbaum).
Source:
Elsevier BV
Antibacterial action of 2-bromo-2-nitropropane-1,3-diol (bronopol).
Source:
American Society for Microbiology
Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
Source:
Public Library of Science (PLoS)
Inhibition of inosine monophosphate dehydrogenase (IMPDH) by the antiviral compound, 2-vinylinosine monophosphate.
Source:
Elsevier BV
In cellulo crystallization of Trypanosoma brucei IMP dehydrogenase enables the identification of genuine co-factors.
Source:
Deutsches Elektronen-Synchrotron, DESY, Hamburg
LeishmaniaGMPR
Source:
Wiley
A Placebo-Controlled, Double-blind Clinical Trial
Source:
Ovid Technologies (Wolters Kluwer Health)
IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex
Source:
Elsevier BV
Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens
Source:
Elsevier BV
IMP dehydrogenase: structure, mechanism, and inhibition.
Source:
American Chemical Society (ACS)
The Behavior and Significance of Slow-Binding Enzyme Inhibitors
Source:
John Wiley & Sons, Inc.
Validation of IMP Dehydrogenase Inhibitors in a Mouse Model of Cryptosporidiosis
Source:
American Society for Microbiology
Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1)
Source:
Royal Society of Chemistry (RSC)
Linking provided by
